Novel Point Mutations and A8027G Polymorphism in Mitochondrial-DNA-Encoded Cytochrome c Oxidase II Gene in Mexican...

Area of Science:

• Genetics
• Neuroscience
• Mitochondrial Biology

Background:

• Mitochondrial dysfunction, including DNA mutations and reactive oxygen species (ROS) production, is implicated in Alzheimer disease (AD) pathogenesis.
• Mitochondrial cytochrome c-oxidase, crucial for energy production, has 13 subunits, with the core catalytic subunits (I, II, III) encoded by mitochondrial DNA.

Purpose of the Study:

• To identify mutations in the mitochondrial cytochrome c-oxidase gene II (MTCO II) in blood samples from Mexican patients with probable AD.
• To explore the potential association between MTCO II mutations and early-onset familial AD.

Main Methods:

• Sequencing of the MTCO II gene in 33 probable AD patients.
• Analysis of identified mutations and polymorphisms for their novelty and association with AD subtypes.

Main Results:

• The A8027G polymorphism was found in 12% of patients, with three cases of early-onset AD (EOAD) and a family history.
• Four EOAD patients presented unique point mutations (A8003C, T8082C, C8201T, G7603A) not previously described in AD.
• The A8027G polymorphism, while previously described, has not been linked to AD.

Conclusions:

• Novel point mutations in the MTCO II gene were identified in Mexican AD patients, particularly in early-onset familial cases.
• These findings suggest that mitochondrial DNA mutations in MTCO II may contribute to AD pathogenesis.
• Further research is required to elucidate the specific role of these mitochondrial DNA point mutations in Alzheimer disease.